Monitoring disease activity using GH and IGF-I in the follow-up of 501 patients with acromegaly.

2.50
Hdl Handle:
http://hdl.handle.net/10147/254133
Title:
Monitoring disease activity using GH and IGF-I in the follow-up of 501 patients with acromegaly.
Authors:
Sherlock, M; Aragon Alonso, A; Reulen, R C; Ayuk, J; Clayton, R N; Holder, G; Sheppard, M C; Bates, A; Stewart, P M
Affiliation:
Division of Medical Sciences, Centre for Endocrinology, Diabetes and Metabolism, University of Birmingham, Birmingham, UK.
Citation:
Monitoring disease activity using GH and IGF-I in the follow-up of 501 patients with acromegaly. 2009, 71 (1):74-81 Clin. Endocrinol. (Oxf)
Publisher:
Clinical endocrinology
Journal:
Clinical endocrinology
Issue Date:
Jul-2009
URI:
http://hdl.handle.net/10147/254133
DOI:
10.1111/j.1365-2265.2008.03461.x
PubMed ID:
19178529
Abstract:
The aims of treatment in patients with acromegaly are to achieve serum GH/IGF-I concentrations associated with cure or normalization of mortality and alleviation of symptoms.
Item Type:
Article
Language:
en
MeSH:
Acromegaly; Adult; Female; Follow-Up Studies; Human Growth Hormone; Humans; Insulin-Like Growth Factor I; Male; Middle Aged; Monitoring, Physiologic; Treatment Outcome; Young Adult
ISSN:
1365-2265

Full metadata record

DC FieldValue Language
dc.contributor.authorSherlock, Men_GB
dc.contributor.authorAragon Alonso, Aen_GB
dc.contributor.authorReulen, R Cen_GB
dc.contributor.authorAyuk, Jen_GB
dc.contributor.authorClayton, R Nen_GB
dc.contributor.authorHolder, Gen_GB
dc.contributor.authorSheppard, M Cen_GB
dc.contributor.authorBates, Aen_GB
dc.contributor.authorStewart, P Men_GB
dc.date.accessioned2012-11-30T16:37:45Z-
dc.date.available2012-11-30T16:37:45Z-
dc.date.issued2009-07-
dc.identifier.citationMonitoring disease activity using GH and IGF-I in the follow-up of 501 patients with acromegaly. 2009, 71 (1):74-81 Clin. Endocrinol. (Oxf)en_GB
dc.identifier.issn1365-2265-
dc.identifier.pmid19178529-
dc.identifier.doi10.1111/j.1365-2265.2008.03461.x-
dc.identifier.urihttp://hdl.handle.net/10147/254133-
dc.description.abstractThe aims of treatment in patients with acromegaly are to achieve serum GH/IGF-I concentrations associated with cure or normalization of mortality and alleviation of symptoms.en_GB
dc.language.isoenen
dc.publisherClinical endocrinologyen_GB
dc.rightsArchived with thanks to Clinical endocrinologyen_GB
dc.subject.meshAcromegaly-
dc.subject.meshAdult-
dc.subject.meshFemale-
dc.subject.meshFollow-Up Studies-
dc.subject.meshHuman Growth Hormone-
dc.subject.meshHumans-
dc.subject.meshInsulin-Like Growth Factor I-
dc.subject.meshMale-
dc.subject.meshMiddle Aged-
dc.subject.meshMonitoring, Physiologic-
dc.subject.meshTreatment Outcome-
dc.subject.meshYoung Adult-
dc.titleMonitoring disease activity using GH and IGF-I in the follow-up of 501 patients with acromegaly.en_GB
dc.typeArticleen
dc.contributor.departmentDivision of Medical Sciences, Centre for Endocrinology, Diabetes and Metabolism, University of Birmingham, Birmingham, UK.en_GB
dc.identifier.journalClinical endocrinologyen_GB
dc.description.provinceLeinsteren

Related articles on PubMed

All Items in Lenus,the Irish health repository are protected by copyright, with all rights reserved, unless otherwise indicated.